Advancing neurofibromatosis and schwannomatosis clinical trial design: Consensus recommendations from the Response Evaluation in Neurofibromatosis and Schwannomatosis (REiNS) International Collaboration
Clin Trials
.
2024 Feb;21(1):3-5.
doi: 10.1177/17407745231201345.
Epub 2023 Sep 29.
Authors
Vanessa L Merker
1
,
Andrea M Gross
2
,
Brigitte C Widemann
2
,
Scott R Plotkin
1
Affiliations
1
Department of Neurology and Cancer Center, Massachusetts General Hospital, Boston, MA, USA.
2
Pediatric Oncology Branch, National Cancer Institute, Bethesda, MD, USA.
PMID:
37776044
PMCID:
PMC10865758
DOI:
10.1177/17407745231201345
No abstract available
MeSH terms
Clinical Trials as Topic
Consensus
Humans
Neurilemmoma*
Neurofibromatoses* / therapy
Skin Neoplasms*
Supplementary concepts
Schwannomatosis
Grants and funding
Z01 BC010801/ImNIH/Intramural NIH HHS/United States